Skip to main content

What the FDA labels say about taking them together

Rifampin and ubrogepant

Ubrogepant's FDA label of June 5, 2025 names rifampin in its drug interactions section; the rifampin label PlainMeds reads does not name ubrogepant. The ubrogepant label: “CYP3A4 I nducers Co-administration of UBRELVY with rifampin, a strong CYP3A4 inducer, resulted in a significant reduction in ubrogepant exposure [ s ee Clinical Pharmacology ].”

Check it at the source: the rifampin FDA label on DailyMed (effective February 11, 2026, Lupin Pharmaceuticals, Inc.); the ubrogepant FDA label on DailyMed (effective June 5, 2025, Allergan, Inc.).

What does the rifampin label say about ubrogepant?

Rifampin's label (effective February 11, 2026) does not name ubrogepant in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (rifampin), Lupin Pharmaceuticals, Inc., effective February 11, 2026 (SPL set b56004f0-f23d-47f6-80c7-39884fccbccc), via openFDA; the full label on DailyMed

What does the ubrogepant label say about rifampin?

Ubrogepant label, drug interactions

CYP3A4 I nducers Co-administration of UBRELVY with rifampin, a strong CYP3A4 inducer, resulted in a significant reduction in ubrogepant exposure [ s ee Clinical Pharmacology ( 12.3 ) ].

Source: FDA drug label (UBRELVY), NDA211765 (Abbvie), as published by Allergan, Inc., effective June 5, 2025 (SPL set fd9f9458-fd96-4688-be3f-f77b3d1af6ab), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

13Rifampin generic labelers
0Ubrogepant generic labelers
RifampinUbrogepant
Labeled forn/aMigraine
Boxed warningNoNo
Pharmacy cost (NADAC)$0.679 per capsule 300 mg capsule$109.11 per tablet 100 mg tablet
Shortage nowIn shortageNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?